Global Human Prothrombin Complex Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 267592
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Human Prothrombin Complex market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Human Prothrombin Complex market size is estimated to be worth US$ 1622.7 million in 2021 and is forecast to a readjusted size of USD 3431.5 million by 2028 with a CAGR of 11.3% during review period. Hemophilia B accounting for % of the Human Prothrombin Complex global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 500 IU/Vial segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Human Prothrombin Complex include Takeda, CSL, Grifols, Octapharma, and Hualan Biological, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Human Prothrombin Complex market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

500 IU/Vial

600 IU/Vial

1000 IU/Vial

Others

Market segment by Application can be divided into

Hemophilia B

Vitamin K Deficiency

Others

The key market players for global Human Prothrombin Complex market are listed below:

Takeda

CSL

Grifols

Octapharma

Hualan Biological

Meheco Xinxing Pharma

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Human Prothrombin Complex product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Human Prothrombin Complex, with price, sales, revenue and global market share of Human Prothrombin Complex from 2019 to 2022.

Chapter 3, the Human Prothrombin Complex competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Human Prothrombin Complex breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Prothrombin Complex market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Human Prothrombin Complex.

Chapter 13, 14, and 15, to describe Human Prothrombin Complex sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Human Prothrombin Complex Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Human Prothrombin Complex Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 500 IU/Vial

1.2.3 600 IU/Vial

1.2.4 1000 IU/Vial

1.2.5 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Human Prothrombin Complex Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hemophilia B

1.3.3 Vitamin K Deficiency

1.3.4 Others

1.4 Global Human Prothrombin Complex Market Size & Forecast

1.4.1 Global Human Prothrombin Complex Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Human Prothrombin Complex Sales in Volume (2017-2028)

1.4.3 Global Human Prothrombin Complex Price (2017-2028)

1.5 Global Human Prothrombin Complex Production Capacity Analysis

1.5.1 Global Human Prothrombin Complex Total Production Capacity (2017-2028)

1.5.2 Global Human Prothrombin Complex Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Human Prothrombin Complex Market Drivers

1.6.2 Human Prothrombin Complex Market Restraints

1.6.3 Human Prothrombin Complex Trends Analysis

2 Manufacturers Profiles

2.1 Takeda

2.1.1 Takeda Details

2.1.2 Takeda Major Business

2.1.3 Takeda Human Prothrombin Complex Product and Services

2.1.4 Takeda Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 CSL

2.2.1 CSL Details

2.2.2 CSL Major Business

2.2.3 CSL Human Prothrombin Complex Product and Services

2.2.4 CSL Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Grifols

2.3.1 Grifols Details

2.3.2 Grifols Major Business

2.3.3 Grifols Human Prothrombin Complex Product and Services

2.3.4 Grifols Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Octapharma

2.4.1 Octapharma Details

2.4.2 Octapharma Major Business

2.4.3 Octapharma Human Prothrombin Complex Product and Services

2.4.4 Octapharma Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Hualan Biological

2.5.1 Hualan Biological Details

2.5.2 Hualan Biological Major Business

2.5.3 Hualan Biological Human Prothrombin Complex Product and Services

2.5.4 Hualan Biological Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Meheco Xinxing Pharma

2.6.1 Meheco Xinxing Pharma Details

2.6.2 Meheco Xinxing Pharma Major Business

2.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Product and Services

2.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Human Prothrombin Complex Breakdown Data by Manufacturer

3.1 Global Human Prothrombin Complex Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Human Prothrombin Complex Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Human Prothrombin Complex

3.4 Market Concentration Rate

3.4.1 Top 3 Human Prothrombin Complex Manufacturer Market Share in 2021

3.4.2 Top 6 Human Prothrombin Complex Manufacturer Market Share in 2021

3.5 Global Human Prothrombin Complex Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Human Prothrombin Complex Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Human Prothrombin Complex Market Size by Region

4.1.1 Global Human Prothrombin Complex Sales in Volume by Region (2017-2028)

4.1.2 Global Human Prothrombin Complex Revenue by Region (2017-2028)

4.2 North America Human Prothrombin Complex Revenue (2017-2028)

4.3 Europe Human Prothrombin Complex Revenue (2017-2028)

4.4 Asia-Pacific Human Prothrombin Complex Revenue (2017-2028)

4.5 South America Human Prothrombin Complex Revenue (2017-2028)

4.6 Middle East and Africa Human Prothrombin Complex Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Human Prothrombin Complex Sales in Volume by Type (2017-2028)

5.2 Global Human Prothrombin Complex Revenue by Type (2017-2028)

5.3 Global Human Prothrombin Complex Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Human Prothrombin Complex Sales in Volume by Application (2017-2028)

6.2 Global Human Prothrombin Complex Revenue by Application (2017-2028)

6.3 Global Human Prothrombin Complex Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Human Prothrombin Complex Sales by Type (2017-2028)

7.2 North America Human Prothrombin Complex Sales by Application (2017-2028)

7.3 North America Human Prothrombin Complex Market Size by Country

7.3.1 North America Human Prothrombin Complex Sales in Volume by Country (2017-2028)

7.3.2 North America Human Prothrombin Complex Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Human Prothrombin Complex Sales by Type (2017-2028)

8.2 Europe Human Prothrombin Complex Sales by Application (2017-2028)

8.3 Europe Human Prothrombin Complex Market Size by Country

8.3.1 Europe Human Prothrombin Complex Sales in Volume by Country (2017-2028)

8.3.2 Europe Human Prothrombin Complex Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Human Prothrombin Complex Sales by Type (2017-2028)

9.2 Asia-Pacific Human Prothrombin Complex Sales by Application (2017-2028)

9.3 Asia-Pacific Human Prothrombin Complex Market Size by Region

9.3.1 Asia-Pacific Human Prothrombin Complex Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Human Prothrombin Complex Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Human Prothrombin Complex Sales by Type (2017-2028)

10.2 South America Human Prothrombin Complex Sales by Application (2017-2028)

10.3 South America Human Prothrombin Complex Market Size by Country

10.3.1 South America Human Prothrombin Complex Sales in Volume by Country (2017-2028)

10.3.2 South America Human Prothrombin Complex Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Human Prothrombin Complex Sales by Type (2017-2028)

11.2 Middle East & Africa Human Prothrombin Complex Sales by Application (2017-2028)

11.3 Middle East & Africa Human Prothrombin Complex Market Size by Country

11.3.1 Middle East & Africa Human Prothrombin Complex Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Human Prothrombin Complex Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Human Prothrombin Complex and Key Manufacturers

12.2 Manufacturing Costs Percentage of Human Prothrombin Complex

12.3 Human Prothrombin Complex Production Process

12.4 Human Prothrombin Complex Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Human Prothrombin Complex Typical Distributors

13.3 Human Prothrombin Complex Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Human Prothrombin Complex Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Human Prothrombin Complex Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Takeda Basic Information, Manufacturing Base and Competitors

Table 4. Takeda Major Business

Table 5. Takeda Human Prothrombin Complex Product and Services

Table 6. Takeda Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. CSL Basic Information, Manufacturing Base and Competitors

Table 8. CSL Major Business

Table 9. CSL Human Prothrombin Complex Product and Services

Table 10. CSL Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Grifols Basic Information, Manufacturing Base and Competitors

Table 12. Grifols Major Business

Table 13. Grifols Human Prothrombin Complex Product and Services

Table 14. Grifols Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Octapharma Basic Information, Manufacturing Base and Competitors

Table 16. Octapharma Major Business

Table 17. Octapharma Human Prothrombin Complex Product and Services

Table 18. Octapharma Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Hualan Biological Basic Information, Manufacturing Base and Competitors

Table 20. Hualan Biological Major Business

Table 21. Hualan Biological Human Prothrombin Complex Product and Services

Table 22. Hualan Biological Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Meheco Xinxing Pharma Basic Information, Manufacturing Base and Competitors

Table 24. Meheco Xinxing Pharma Major Business

Table 25. Meheco Xinxing Pharma Human Prothrombin Complex Product and Services

Table 26. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Global Human Prothrombin Complex Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 28. Global Human Prothrombin Complex Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 29. Market Position of Manufacturers in Human Prothrombin Complex, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 30. Global Human Prothrombin Complex Production Capacity by Company, (K Units): 2020 VS 2021

Table 31. Head Office and Human Prothrombin Complex Production Site of Key Manufacturer

Table 32. Human Prothrombin Complex New Entrant and Capacity Expansion Plans

Table 33. Human Prothrombin Complex Mergers & Acquisitions in the Past Five Years

Table 34. Global Human Prothrombin Complex Sales by Region (2017-2022) & (K Units)

Table 35. Global Human Prothrombin Complex Sales by Region (2023-2028) & (K Units)

Table 36. Global Human Prothrombin Complex Revenue by Region (2017-2022) & (USD Million)

Table 37. Global Human Prothrombin Complex Revenue by Region (2023-2028) & (USD Million)

Table 38. Global Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 39. Global Human Prothrombin Complex Sales by Type (2023-2028) & (K Units)

Table 40. Global Human Prothrombin Complex Revenue by Type (2017-2022) & (USD Million)

Table 41. Global Human Prothrombin Complex Revenue by Type (2023-2028) & (USD Million)

Table 42. Global Human Prothrombin Complex Price by Type (2017-2022) & (M USD/Unit)

Table 43. Global Human Prothrombin Complex Price by Type (2023-2028) & (M USD/Unit)

Table 44. Global Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 45. Global Human Prothrombin Complex Sales by Application (2023-2028) & (K Units)

Table 46. Global Human Prothrombin Complex Revenue by Application (2017-2022) & (USD Million)

Table 47. Global Human Prothrombin Complex Revenue by Application (2023-2028) & (USD Million)

Table 48. Global Human Prothrombin Complex Price by Application (2017-2022) & (M USD/Unit)

Table 49. Global Human Prothrombin Complex Price by Application (2023-2028) & (M USD/Unit)

Table 50. North America Human Prothrombin Complex Sales by Country (2017-2022) & (K Units)

Table 51. North America Human Prothrombin Complex Sales by Country (2023-2028) & (K Units)

Table 52. North America Human Prothrombin Complex Revenue by Country (2017-2022) & (USD Million)

Table 53. North America Human Prothrombin Complex Revenue by Country (2023-2028) & (USD Million)

Table 54. North America Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 55. North America Human Prothrombin Complex Sales by Type (2023-2028) & (K Units)

Table 56. North America Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 57. North America Human Prothrombin Complex Sales by Application (2023-2028) & (K Units)

Table 58. Europe Human Prothrombin Complex Sales by Country (2017-2022) & (K Units)

Table 59. Europe Human Prothrombin Complex Sales by Country (2023-2028) & (K Units)

Table 60. Europe Human Prothrombin Complex Revenue by Country (2017-2022) & (USD Million)

Table 61. Europe Human Prothrombin Complex Revenue by Country (2023-2028) & (USD Million)

Table 62. Europe Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 63. Europe Human Prothrombin Complex Sales by Type (2023-2028) & (K Units)

Table 64. Europe Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 65. Europe Human Prothrombin Complex Sales by Application (2023-2028) & (K Units)

Table 66. Asia-Pacific Human Prothrombin Complex Sales by Region (2017-2022) & (K Units)

Table 67. Asia-Pacific Human Prothrombin Complex Sales by Region (2023-2028) & (K Units)

Table 68. Asia-Pacific Human Prothrombin Complex Revenue by Region (2017-2022) & (USD Million)

Table 69. Asia-Pacific Human Prothrombin Complex Revenue by Region (2023-2028) & (USD Million)

Table 70. Asia-Pacific Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 71. Asia-Pacific Human Prothrombin Complex Sales by Type (2023-2028) & (K Units)

Table 72. Asia-Pacific Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 73. Asia-Pacific Human Prothrombin Complex Sales by Application (2023-2028) & (K Units)

Table 74. South America Human Prothrombin Complex Sales by Country (2017-2022) & (K Units)

Table 75. South America Human Prothrombin Complex Sales by Country (2023-2028) & (K Units)

Table 76. South America Human Prothrombin Complex Revenue by Country (2017-2022) & (USD Million)

Table 77. South America Human Prothrombin Complex Revenue by Country (2023-2028) & (USD Million)

Table 78. South America Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 79. South America Human Prothrombin Complex Sales by Type (2023-2028) & (K Units)

Table 80. South America Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 81. South America Human Prothrombin Complex Sales by Application (2023-2028) & (K Units)

Table 82. Middle East & Africa Human Prothrombin Complex Sales by Region (2017-2022) & (K Units)

Table 83. Middle East & Africa Human Prothrombin Complex Sales by Region (2023-2028) & (K Units)

Table 84. Middle East & Africa Human Prothrombin Complex Revenue by Region (2017-2022) & (USD Million)

Table 85. Middle East & Africa Human Prothrombin Complex Revenue by Region (2023-2028) & (USD Million)

Table 86. Middle East & Africa Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 87. Middle East & Africa Human Prothrombin Complex Sales by Type (2023-2028) & (K Units)

Table 88. Middle East & Africa Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 89. Middle East & Africa Human Prothrombin Complex Sales by Application (2023-2028) & (K Units)

Table 90. Human Prothrombin Complex Raw Material

Table 91. Key Manufacturers of Human Prothrombin Complex Raw Materials

Table 92. Direct Channel Pros & Cons

Table 93. Indirect Channel Pros & Cons

Table 94. Human Prothrombin Complex Typical Distributors

Table 95. Human Prothrombin Complex Typical Customers

List of Figures

Figure 1. Human Prothrombin Complex Picture

Figure 2. Global Human Prothrombin Complex Revenue Market Share by Type in 2021

Figure 3. 500 IU/Vial

Figure 4. 600 IU/Vial

Figure 5. 1000 IU/Vial

Figure 6. Others

Figure 7. Global Human Prothrombin Complex Revenue Market Share by Application in 2021

Figure 8. Hemophilia B

Figure 9. Vitamin K Deficiency

Figure 10. Others

Figure 11. Global Human Prothrombin Complex Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 12. Global Human Prothrombin Complex Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Human Prothrombin Complex Sales (2017-2028) & (K Units)

Figure 14. Global Human Prothrombin Complex Price (2017-2028) & (M USD/Unit)

Figure 15. Global Human Prothrombin Complex Production Capacity (2017-2028) & (K Units)

Figure 16. Global Human Prothrombin Complex Production Capacity by Geographic Region: 2022 VS 2028

Figure 17. Human Prothrombin Complex Market Drivers

Figure 18. Human Prothrombin Complex Market Restraints

Figure 19. Human Prothrombin Complex Market Trends

Figure 20. Global Human Prothrombin Complex Sales Market Share by Manufacturer in 2021

Figure 21. Global Human Prothrombin Complex Revenue Market Share by Manufacturer in 2021

Figure 22. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 23. Top 3 Human Prothrombin Complex Manufacturer (Revenue) Market Share in 2021

Figure 24. Top 6 Human Prothrombin Complex Manufacturer (Revenue) Market Share in 2021

Figure 25. Global Human Prothrombin Complex Sales Market Share by Region (2017-2028)

Figure 26. Global Human Prothrombin Complex Revenue Market Share by Region (2017-2028)

Figure 27. North America Human Prothrombin Complex Revenue (2017-2028) & (USD Million)

Figure 28. Europe Human Prothrombin Complex Revenue (2017-2028) & (USD Million)

Figure 29. Asia-Pacific Human Prothrombin Complex Revenue (2017-2028) & (USD Million)

Figure 30. South America Human Prothrombin Complex Revenue (2017-2028) & (USD Million)

Figure 31. Middle East & Africa Human Prothrombin Complex Revenue (2017-2028) & (USD Million)

Figure 32. Global Human Prothrombin Complex Sales Market Share by Type (2017-2028)

Figure 33. Global Human Prothrombin Complex Revenue Market Share by Type (2017-2028)

Figure 34. Global Human Prothrombin Complex Price by Type (2017-2028) & (M USD/Unit)

Figure 35. Global Human Prothrombin Complex Sales Market Share by Application (2017-2028)

Figure 36. Global Human Prothrombin Complex Revenue Market Share by Application (2017-2028)

Figure 37. Global Human Prothrombin Complex Price by Application (2017-2028) & (M USD/Unit)

Figure 38. North America Human Prothrombin Complex Sales Market Share by Type (2017-2028)

Figure 39. North America Human Prothrombin Complex Sales Market Share by Application (2017-2028)

Figure 40. North America Human Prothrombin Complex Sales Market Share by Country (2017-2028)

Figure 41. North America Human Prothrombin Complex Revenue Market Share by Country (2017-2028)

Figure 42. United States Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Canada Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Mexico Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Europe Human Prothrombin Complex Sales Market Share by Type (2017-2028)

Figure 46. Europe Human Prothrombin Complex Sales Market Share by Application (2017-2028)

Figure 47. Europe Human Prothrombin Complex Sales Market Share by Country (2017-2028)

Figure 48. Europe Human Prothrombin Complex Revenue Market Share by Country (2017-2028)

Figure 49. Germany Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. France Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. United Kingdom Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Russia Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Italy Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Asia-Pacific Human Prothrombin Complex Sales Market Share by Region (2017-2028)

Figure 55. Asia-Pacific Human Prothrombin Complex Sales Market Share by Application (2017-2028)

Figure 56. Asia-Pacific Human Prothrombin Complex Sales Market Share by Region (2017-2028)

Figure 57. Asia-Pacific Human Prothrombin Complex Revenue Market Share by Region (2017-2028)

Figure 58. China Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Japan Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Korea Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. India Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Southeast Asia Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Australia Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South America Human Prothrombin Complex Sales Market Share by Type (2017-2028)

Figure 65. South America Human Prothrombin Complex Sales Market Share by Application (2017-2028)

Figure 66. South America Human Prothrombin Complex Sales Market Share by Country (2017-2028)

Figure 67. South America Human Prothrombin Complex Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East & Africa Human Prothrombin Complex Sales Market Share by Type (2017-2028)

Figure 71. Middle East & Africa Human Prothrombin Complex Sales Market Share by Application (2017-2028)

Figure 72. Middle East & Africa Human Prothrombin Complex Sales Market Share by Region (2017-2028)

Figure 73. Middle East & Africa Human Prothrombin Complex Revenue Market Share by Region (2017-2028)

Figure 74. Turkey Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Egypt Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Saudi Arabia Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. South Africa Human Prothrombin Complex Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Manufacturing Cost Structure Analysis of Human Prothrombin Complex in 2021

Figure 79. Manufacturing Process Analysis of Human Prothrombin Complex

Figure 80. Human Prothrombin Complex Industrial Chain

Figure 81. Sales Channel: Direct Channel vs Indirect Channel

Figure 82. Methodology

Figure 83. Research Process and Data Source